Nanobiotix sa - adr NBTX.US Overview Analysis
)NBTX AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
With insufficient quarterly financial data released by the company, we're unable to provide a rating.
NBTX Current Performance
1.52%
Nanobiotix sa - adr
1.31%
Avg of Sector
0.58%
S&P500
Top 10 High Relevance to NBTX
- NERV Minerva neurosciences incValue 3Trend 2Swing Trading 4Whale Interest 1Dividend 1See more
NBTX Profile
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.